CVS Health Corporation (NEO:CVS)
Canada · Delayed Price · Currency is CAD 19.17
-0.02 (-0.10%)
Nov 7, 2025, 4:00 PM EST
CVS Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 469 | 4,614 | 8,344 | 4,311 | 8,001 | 7,179 | Upgrade |
Depreciation & Amortization | 4,606 | 4,597 | 4,366 | 4,224 | 4,486 | 4,441 | Upgrade |
Loss (Gain) From Sale of Assets | -247 | - | 349 | 2,058 | - | -269 | Upgrade |
Asset Writedown & Restructuring Costs | 5,725 | 840 | 152 | - | 1,789 | - | Upgrade |
Stock-Based Compensation | 537 | 540 | 588 | 447 | 484 | 400 | Upgrade |
Other Operating Activities | -1,134 | -1,593 | -388 | -1,681 | -352 | 955 | Upgrade |
Change in Accounts Receivable | -7,852 | -1,301 | -6,260 | -2,971 | -2,703 | -1,510 | Upgrade |
Change in Inventory | -1,439 | -102 | 1,233 | -1,435 | 735 | -973 | Upgrade |
Change in Accounts Payable | 5,218 | 2,335 | 3,618 | 4,260 | 2,898 | 2,769 | Upgrade |
Change in Other Net Operating Assets | 3,226 | -823 | 1,424 | 6,964 | 2,927 | 2,873 | Upgrade |
Operating Cash Flow | 9,109 | 9,107 | 13,426 | 16,177 | 18,265 | 15,865 | Upgrade |
Operating Cash Flow Growth | 97.55% | -32.17% | -17.01% | -11.43% | 15.13% | 23.48% | Upgrade |
Capital Expenditures | -2,816 | -2,781 | -3,031 | -2,727 | -2,520 | -2,437 | Upgrade |
Cash Acquisitions | -439 | -95 | -16,612 | -139 | -146 | -866 | Upgrade |
Divestitures | - | - | - | -1,249 | - | 840 | Upgrade |
Investment in Securities | -1,200 | -4,838 | -1,314 | -1,017 | -2,717 | -3,172 | Upgrade |
Other Investing Activities | 35 | 101 | 68 | 85 | 122 | 101 | Upgrade |
Investing Cash Flow | -4,420 | -7,613 | -20,889 | -5,047 | -5,261 | -5,534 | Upgrade |
Short-Term Debt Issued | - | 1,919 | 5,200 | - | - | - | Upgrade |
Long-Term Debt Issued | - | 7,913 | 10,898 | - | 987 | 9,958 | Upgrade |
Total Debt Issued | 8,242 | 9,832 | 16,098 | - | 987 | 9,958 | Upgrade |
Short-Term Debt Repaid | - | - | -5,000 | - | - | - | Upgrade |
Long-Term Debt Repaid | - | -4,773 | -3,166 | -4,211 | -10,254 | -15,631 | Upgrade |
Total Debt Repaid | -7,548 | -4,773 | -8,166 | -4,211 | -10,254 | -15,631 | Upgrade |
Net Debt Issued (Repaid) | 694 | 5,059 | 7,932 | -4,211 | -9,267 | -5,673 | Upgrade |
Issuance of Common Stock | 327 | 361 | 277 | 551 | 549 | 264 | Upgrade |
Repurchase of Common Stock | -149 | -3,208 | -2,193 | -3,870 | -168 | -88 | Upgrade |
Common Dividends Paid | -3,390 | -3,373 | -3,132 | -2,907 | -2,625 | -2,624 | Upgrade |
Other Financing Activities | 41 | 26 | -201 | -79 | 155 | 425 | Upgrade |
Financing Cash Flow | -2,477 | -1,135 | 2,683 | -10,516 | -11,356 | -7,696 | Upgrade |
Net Cash Flow | 2,212 | 359 | -4,780 | 614 | 1,648 | 2,635 | Upgrade |
Free Cash Flow | 6,293 | 6,326 | 10,395 | 13,450 | 15,745 | 13,428 | Upgrade |
Free Cash Flow Growth | 273.03% | -39.14% | -22.71% | -14.58% | 17.26% | 29.23% | Upgrade |
Free Cash Flow Margin | 1.61% | 1.71% | 2.92% | 4.18% | 5.41% | 5.01% | Upgrade |
Free Cash Flow Per Share | 4.97 | 5.01 | 8.06 | 10.17 | 11.85 | 10.22 | Upgrade |
Cash Interest Paid | 3,047 | 2,909 | 2,418 | 2,239 | 2,469 | 2,904 | Upgrade |
Cash Income Tax Paid | 1,442 | 1,703 | 3,524 | 4,116 | 3,195 | 2,929 | Upgrade |
Levered Free Cash Flow | 6,839 | 6,909 | 11,075 | 11,935 | 14,783 | 12,871 | Upgrade |
Unlevered Free Cash Flow | 8,770 | 8,758 | 12,737 | 13,365 | 16,347 | 14,687 | Upgrade |
Change in Working Capital | -847 | 109 | 15 | 6,818 | 3,857 | 3,159 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.